the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)	Respiration Disorders, persistent fetal circulation syndrome, respiratory failure, respiratory system disorder	Active, not recruiting	Phase 3	2025-11-18		NCT05527704

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jagiellonian University	43
Jan Biziel University Hospital No 2 in Bydgoszcz	3
Medical University of Warsaw	89
Neonatology Unit, Specialist Hospital No 2, Bytom	1
Neonatology Unit, Szpital Specjalistyczny Pro-Familia, Rzeszow	1
Pomeranian Medical University Szczecin	21
Poznan University of Medical Sciences	53
SZPITAL SPECJALISTYCZNY IM. ŚW. RODZINY w Warszawie	1
University in Zielona Góra	3
University of Ottawa	69
University of Rzeszow	13

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Medical University of Warsaw	Warsaw	Poland	12